Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI

The "Swiss Army Knife" Longevity Target NLRP3 Strikes Again

This post is not an investment advise or any form of endorsement of any of the drugs. To my knowledge, all of the NLRP3 drugs are investigational and…

Nov 4 • 

Alex Zhavoronkov

11

3

1

October 2025

The Ozempic For Sleep? How A New Class of ‘On/Off’ Switch Drugs Could Help With Insomnia and Ward Off Dementia

My Favorite Drug and My Next Favorite Anti-Drug: A Personal Journey into Sleep Optimization

Oct 28 • 

Alex Zhavoronkov

17

6

September 2025

AI as a Stakeholder: What Every Pharma CEO Should Know About Communicating with AI

Communicating with AI today and in the future may require new levels of intensity, transparency, and communication mediums

Sep 23 • 

Alex Zhavoronkov

19

1

GLP-1s: The world's first longevity drug?

The "DeepSeek Moment" in the longevity biotechnology we've all been waiting for transpired on August 29, 2025 at the 12th ARDD meeting in Copenhagen

Sep 9 • 

Alex Zhavoronkov

42

2

2

August 2025

Beyond GLP-1: Is NLRP3 the Next Trillion Dollar Target?

This 24-year-old target demonstrates promise across multiple chronic diseases and has been prioritized by two AI-driven longevity companies. The quality…

Aug 12 • 

Alex Zhavoronkov

30

2

Decoding Longevity: How AI is Ranking the Top Pharma Players

Have you ever wondered which pharmaceutical companies have extended human longevity in the past—and which ones will shape its future?

Aug 7 • 

Alex Zhavoronkov

33

3

1

July 2025

Hacking Humanity: How technology can save your health and your life

New longevity book by Lara Lewington (BBC Journalist, television presenter)

Jul 10 • 

Alex Zhavoronkov

13

3

June 2025

Super Agers - Eric Topol's New Longevity Book

I have a confession to make: I'm working on a new longevity book.

Jun 8 • 

Alex Zhavoronkov

22

3

5

May 2025

23andMe and the Future of Human Genomic Data Privacy and Security

Over 15 million genomes with profile and metadata used, hacked, bankrupted, then sold for $256 Million. What lessons did we learn?

May 28 • 

Alex Zhavoronkov

6

Does Taurine Supplementation Promote Cancer or Extend Lifespan? Or Both?

New paper in Nature uncovers scary facts that can be easily misinterpreted

May 15 • 

Alex Zhavoronkov

12

2

Toward Pharmaceutical Superintelligence

Will we ever see perfect safe real-time cures on demand and where are we today?

May 12 • 

Alex Zhavoronkov

14

1